Below are the most recent publications written about "National Cancer Institute (U.S.)" by people in Profiles.
-
Cosgrove CM, Zamarin D, Conejo-Garcia JR, Hacker KE, Vargas R, Konstantinopoulos PA, Mahdi HS, Gaillard S, Markovina S, Kohn EC, Adams SF. A working group report from the 2024 National Cancer Institute / Gynecologic Cancer Steering Committee endometrial cancer clinical trials planning meeting: refining the approach to endometrial cancer in the immunotherapy era. J Natl Cancer Inst. 2025 Sep 01; 117(9):1774-1783.
-
Mobley EM, Wolfson JA, Levine J, Ji L, Ramakrishnan S, Nightingale CL, Dressler EV, Kittel C, Freyer DR, Sugalski AJ, Prasad PK, Bhutada JS, Murphy K, Kyono W, Roth ME, Parsons SK, Beauchemin MP. Fertility Preservation Services for Adolescents and Young Adults: 2022 National Cancer Institute Community Oncology Research Program Landscape Assessment. JCO Oncol Pract. 2026 Jan; 22(1):112-121.
-
Robles JM, Dressler EV, Kittel C, Nightingale CL, Kyono WT, Santacroce SJ, Salsman JM, Montez K, Prasad P, Sugalski AJ, Ohlsen TJD, Zheng DJ, Parsons SK, Beauchemin MP. Financial Distress Screening and Navigation in Pediatric Oncology Within the National Cancer Institute Community Oncology Research Program. JCO Oncol Pract. 2025 May; 21(5):629-636.
-
Baral A, Diggs BA, Aka A, Williams R, Ortega NH, Fellah RME, Islam JY, Camacho-Rivera M, Penedo FJ, Vidot DC. Experiences and Comfort of Young Cancer Patients Discussing Cannabis with Their Providers: Insights from a Survey at an NCI-Designated Cancer Center. J Cancer Educ. 2025 Apr; 40(2):256-265.
-
Vidot DC, Baral A, Hernandez-Ortega N, Diggs BA, Islam JY, Camacho-Rivera M, Martinez C, Penedo F. Ethnic differences in the patterns, sources, and reasons for cannabis use among cancer patients at an NCI-Designated Cancer Center. J Natl Cancer Inst Monogr. 2024 Aug 15; 2024(66):252-258.
-
Sanchez P, Van Dyke AL, Petkov VI, Yuan Y, Bonds S, Valenzuela C, Tuan AW, Moravec R, Altekruse SF, Singhi AD, Serdy KM, Wu Y, Cress RD, Doherty JA, Mueller L, Hernandez BY, Lynch CF, Tucker TC, Wu XC, Matrisian L, Penberthy L. NCI SEER-Linked Virtual Tissue Repository Pilot. J Natl Cancer Inst Monogr. 2024 Aug 01; 2024(65):180-190.
-
Petkov VI, Byun JS, Ward KC, Schussler NC, Archer NP, Bentler S, Doherty JA, Durbin EB, Gershman ST, Cheng I, Insaf T, Gonsalves L, Hernandez BY, Koch L, Liu L, Monnereau A, Morawski BM, Schwartz SM, Stroup A, Wiggins C, Wu XC, Bonds S, Negoita S, Penberthy L. Reporting tumor genomic test results to SEER registries via linkages. J Natl Cancer Inst Monogr. 2024 Aug 01; 2024(65):168-179.
-
BrintzenhofeSzoc K, Canin B, Casas-Silva E, Denicoff A, Braun-Inglis C, Okado I, Bakos A. Through the Lens of Patient Partners: Challenges in Accrual of Older Adults to NCI Clinical Trials. J Natl Cancer Inst Monogr. 2022 12 15; 2022(60):125-134.
-
Khaled HM, Soliman AS. Medical Oncology Education in Egypt Over the Past 50 Years: the Experience of the National Cancer Institute of Cairo University. J Cancer Educ. 2021 07; 36(Suppl 1):87-94.
-
Haq AA, Reitzel LR, Chen TA, Chang S, Escoto KH, Solari Williams KD, Roberson C, Koshy L, McNeill LH. "UHAND"-A National Cancer Institute Funded Partnership to Advance Cancer Health Equity through Scholar Training. Int J Environ Res Public Health. 2021 05 11; 18(10).